Related references
Note: Only part of the references are listed.AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Amit G. Singal et al.
HEPATOLOGY (2023)
Report of the 22nd nationwide follow-up Survey of Primary Liver Cancer in Japan (2012-2013)
Masatoshi Kudo et al.
HEPATOLOGY RESEARCH (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?
Diamantis Tsilimigras et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria
Diamantis I. Tsilimigras et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Long-term survival and recurrence after curative resection for hepatocellular carcinoma in patients with chronic hepatitis C virus infection: a multicenter observational study from China
Hong Zhu et al.
HPB (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study
Xiu-Ping Zhang et al.
EJSO (2019)
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification
Diamantis Tsilimigras et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
Lucia Cerrito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study
Xiu-Ping Zhang et al.
HEPATOLOGY (2019)
Surgical Resection Versus Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question
Ismail Labgaa et al.
HEPATOLOGY (2019)
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients
Diamantis I. Tsilimigras et al.
SURGERY (2019)
Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
Myung Han Hyun et al.
HEPATOLOGY (2018)
Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages
Hui Guo et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Vascular Invasion and Metastasis is Predictive of Outcome in Barcelona Clinic Liver.Cancer Stage C Hepatocellular Carcinoma
Ali A. Mokdad et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Comparison of hepatocellular carcinoma in Eastern versus Western populations
Su Pin Choo et al.
CANCER (2016)
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
Takashi Kokudo et al.
JOURNAL OF HEPATOLOGY (2016)
Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma
Hiroshi Wada et al.
SURGERY (2016)
Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2015)
Surgical management of hepatocellular carcinoma
Tony C. Y. Pang et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome
Adam C. Yopp et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Risk Stratification of 7,732 Hepatectomy Cases in 2011 from the National Clinical Database for Japan
Akira Kenjo et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group
Guido Torzilli et al.
ANNALS OF SURGERY (2013)
Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
Jian-Hong Zhong et al.
PLOS ONE (2013)
2012 Liver resections in the 21st century: we are far from zero mortality
Safi Dokmak et al.
HPB (2013)
Liver Cancer: Still a Long Way To Go
Jordi Bruix
HEPATOLOGY (2011)
Clinical Decision Making and Research in Hepatocellular Carcinoma: Pivotal Role of Imaging Techniques
Jordi Bruix et al.
HEPATOLOGY (2011)
A new classification for hepatocellular carcinoma with portal vein tumor thrombus
Jie Shi et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2011)
Importance of Low Preoperative Platelet Count in Selecting Patients for Resection of Hepatocellular Carcinoma: A Multi-Institutional Analysis
Shishir K. Maithel et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2011)
Surgical Strategy for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Based on Prognostic Factors
Kazuhiro Kondo et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Perioperative Risk Assessment for Hepatocellular Carcinoma by Using the MELD Score
Spiros G. Delis et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection
Durgatosh Pandey et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis
Alessandro Cucchetti et al.
LIVER TRANSPLANTATION (2006)
Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
SH Teh et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
The 50-50 criteria on postoperative day 5 - An accurate predictor of liver failure and death after hepatectomy
S Balzan et al.
ANNALS OF SURGERY (2005)
Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma
TM Pawlik et al.
ARCHIVES OF SURGERY (2005)
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database
KK Ng et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Progress in surgical treatment of hepatocellular carcinoma
M Makuuchi et al.
ONCOLOGY (2002)
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
M Malinchoc et al.
HEPATOLOGY (2000)
Share Paper
